Physician

Kavita Nirmal, M.D.

According to 2025 Medicare claims, Kavita Nirmal, M.D. (NPI: 1760619621) practices hematology/oncology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75601-4717.

Nirmal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 900 traditional Medicare patients, billed 153,724 HCPCS/CPT codes, and received $2,086,257 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,833 prescription claims across 283 beneficiaries totaling $1,942,369 in drug costs, led by Kisqali (Ribociclib Succinate). DME data shows 13 claims. Open Payments data shows 41 records totaling $870. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,143,409 to $2,086,257. Similarly, Part D prescription costs have risen steadily, from $526,082 to $1,942,369. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,287 to $3,851.